Clinical trials of potential antidepressants: to what extent are the elderly represented: a review
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: There is widespread use of antidepressants in the elderly population. The principle of treatment of depression, however, is derived mostly from studies employing young adults and healthy elderly. This article reviews the literature on the extent to which the elderly are represented in clinical trials of potential antidepressants. Method: Medline search of relevant articles of clinical trials of potential antidepressants. Results: The maximum age of inclusion for most clinical trials was 65 years. The highest age reported for depressed subjects was 90 years. There was no clear consensus on who were considered to be elderly; clinical trials conducted on the elderly included subjects who were 50, 55, or 60 years and over. Pharmacological studies on healthy subjects were most often done on young adults, age range 18 to 65 years. The period of study was relatively shorter for clinical trials done on elderly subjects. There was however, no difference in the exclusion or inclusion criteria between studies done in young and elderly subjects. Conclusions: Elderly subjects aged 75 years and over were clearly underrepresented in the clinical trials of potential antidepressants. For drugs that are used by the elderly, in its pivotal studies for registration, the inclusion of at least 25% of subjects aged 75 years and over is recommended. Copyright © 2005 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of the antidepressant Org 3770 on human sleep
Ruigt, G. S. F., Kemp, B., Groenhout, C. M., & Kamphuisen, H. A. C. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278580 · Cited by 110
Saletu, B., Gr�nberger, J., & Linzmayer, L. (1986) · Journal of Neural Transmission · doi:10.1007/bf01243351 · Cited by 78
Cited by
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
“The under-representation of older people in clinical trials of antidepressants and the fact that most such trials are short term make deriving reliable or precise estimates of the incidence of adverse events in this group difficult.”
BackgroundThorlund, K., Druyts, E., Wu, P., Balijepalli, C., Keohane, D., & Mills, E. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13395 · Cited by 79
“ally, in clinical trials of antidepressants, there is an underrepresentation of older adults.(18,19) Older adults have a higher proportion of comorbidities that might lead to more adverse events because of polypharmacy.”
BackgroundSystematic review: representativeness of participants in RCTs of acetylcholinesterase inhibitors
Leinonen, A., Koponen, M., & Hartikainen, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124500 · Cited by 64
Determinants of brain SPECT perfusion and connectivity in treatment-resistant depression
Richieri, R., Boyer, L., Faget-Agius, C., Farisse, J., Mundler, O., Lançon, C., & Guedj, E. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.11.013 · Cited by 14
Metadata
- Authors
- Giron, M. S. T., Fastbom, J., & Winblad, B.
- Venue
- International Journal of Geriatric Psychiatry
- Publisher
- Wiley
- Published
- 2005-02-16
- Volume
- 20
- Issue
- 3
- Pages
- 201-217
- ISSN
- 0885-6230 (ISSN-L)
- 1099-1166
- OpenAlex
- W2131924085
- Cited by
- 49
- References
- 2
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.